Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Fathers for Change for Men With Co-occurring Domestic Violence and Substance Abuse

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Carla Stover, Yale University
ClinicalTrials.gov Identifier:
NCT01385553
First received: June 14, 2011
Last updated: February 18, 2014
Last verified: February 2014
  Purpose

Social service systems rarely acknowledge the status of men as fathers in the conceptualization and delivery of treatment for substance abuse or domestic violence. Although there has been extensive focus on the treatment of mothers who abuse substances, are victims of intimate partner violence (IPV) (defined as physical aggression and/or psychological abuse and control at the hands of an intimate partner), or maltreat their children there has been little consideration of the need for interventions for fathers with histories of co-morbid IPV and substance abuse. It is estimated that between 10 and 17.8 million children are witness to violence in their homes each year. National and regional samples indicate 50-70% of families impacted by IPV and the typically co-occurring substance abuse have children under the age of seven. Large percentages of these men continue to live with or have consistent contact with their young children despite aggression and substance use.

Court mandated treatments for perpetrators of domestic violence have become the norm, however the efficacy of these treatments is questionable and most do not speak to the broader needs of batterers and their families. How batterer's treatments might impact parenting and father-child relationships and the psychosocial functioning of children is vastly understudied and not currently understood. Since batterer treatments are court mandated and require tremendous financial and community resources, the efficacy of these interventions in stopping the cycle of domestic violence and improving the health and well-being of the batterer, his partner and children is crucial. There are currently NO evidence-based treatments that address co-morbid substance abuse and domestic violence perpetration with emphasis on paternal parenting and the father-child relationship. Consequently, the proposed psychotherapy development project will develop and evaluate the potential efficacy of a novel, relational parent intervention for fathers with co-morbid substance abuse and IPV who have young children. The goals of this intervention are to decrease aggression and substance abuse by increasing focus on fathering and an improved father-child relationship.


Condition Intervention Phase
Domestic Violence
Substance Abuse
Parenting
Behavioral: Fathers for Change
Behavioral: Individual Drug Counseling
Phase 1
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Randomized Trial of Fathers for Change: An Intervention for Fathers With Co-Occuring Domestic Violence and Substance Abuse

Resource links provided by NLM:


Further study details as provided by Yale University:

Primary Outcome Measures:
  • Decrease in Verbal and Physical Aggression [ Time Frame: Baseline (Start of Tx), 4 month follow-up, 7 month follow-up ] [ Designated as safety issue: Yes ]
    Conflict Tactics Scale and the TimeLine Follow-back calendar interview

  • Decrease in Substance Abuse [ Time Frame: weekly for months 1-4, 7 month followup ] [ Designated as safety issue: Yes ]
    urinalysis results and self report

  • Decrease in Negative Parenting Behavior [ Time Frame: baseline, 4 month, 7 month follow-up ] [ Designated as safety issue: Yes ]
    IOWA, Adult child relationship questionnaire, Parental Acceptance Rejection Questionnaire


Enrollment: 20
Study Start Date: June 2011
Study Completion Date: June 2013
Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Individual Drug Counseling Behavioral: Individual Drug Counseling
Individual drug counseling focuses on the symptoms of drug addiction and related areas of impaired functioning and the content and structure of the patient's ongoing recovery program. This model of counseling is time limited and emphasizes behavioral change. It gives the patient coping strategies and tools for recovery and promotes 12-step ideology and participation. The primary goal of addiction counseling is to assist the addict in achieving and maintaining abstinence from addictive chemicals and behaviors. The secondary goal is to help the addict recover from the damage the addiction has caused in his or her life.
Other Name: IDC
Experimental: Fathers for Change Behavioral: Fathers for Change
FATHERS FOR CHANGE comprises 16, 60 minute sessions of treatment utilizing components of three evidence based practices: SADV-Cognitive Behavioral Therapy, Behavioral Couple Therapy and Child-Parent Psychotherapy. The goals of the intervention are: 1) decreased substance abuse and IPV by teaching coping and anger management skills, 2) improved communication and increased problem solving around shared parenting 3) parenting education including child development and the impact of violence on children, 4) discussion of discipline practices and development of behavior modification or positive reinforcement plans, and 5) attachment focused parent-child play sessions to coach fathers in play with their children and process traumatic experiences.
Other Name: Integrated Father Treatment for Domestic Violence

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. meet current DSM-IV criteria for substance abuse and who have used a substance within the 60 days prior to screening;
  2. have a police reported incident of IPV (pushing, slapping, kicking) within 6 months of referral;
  3. have at least one biological child under the age of 7 with whom they reside or have at least weekly visitation.

Exclusion Criteria:

  1. Have histories of severe physical violence (e.g. choking, causing hospitalization);
  2. Men who have an active NO CONTACT protective order pertaining to their partner or child;
  3. Men whose female partners indicate that they do not want the child to participate;
  4. If the female partner indicates that she believes her child is afraid of his/her father and will NOT want to participate;
  5. Men who are currently in withdrawal from substances and in need of detoxification;
  6. Have cognitive impairment or a lifetime history of any psychotic or bipolar disorder; or
  7. Are currently suicidal or homicidal.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01385553

Locations
United States, Connecticut
Yale University
New Haven, Connecticut, United States, 06510
Sponsors and Collaborators
Yale University
Investigators
Principal Investigator: Carla S Stover, Ph.D. Yale University
  More Information

Publications:
Responsible Party: Carla Stover, Assistant Professor, Yale University
ClinicalTrials.gov Identifier: NCT01385553     History of Changes
Other Study ID Numbers: 1003006541, 1K23DA023334-01A2
Study First Received: June 14, 2011
Last Updated: February 18, 2014
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders

ClinicalTrials.gov processed this record on November 23, 2014